Company intelligence
SciNeuro Pharmaceuticals
Deliver Transformative Medicine for CNS Diseases
Biotechnology Research
Rockville, US
33 employees
Founded 2020
1 public signals
About SciNeuro Pharmaceuticals
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer’s disease, Parkinson’s disease, and other devastating CNS diseases.
Verified activity
Signals from SciNeuro Pharmaceuticals
1 published signal